MIANSERIN 2-OXIDE

Details

Stereochemistry	MIXED
Molecular Formula	C18H20N2O
Molecular Weight	280.3642
Optical Activity	UNSPECIFIED
Defined Stereocenters	0 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[N+]1([O-])CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C24

InChI

InChIKey=VVDXWJOYXVNLLQ-UHFFFAOYSA-N

InChI=1S/C18H20N2O/c1-20(21)11-10-19-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(19)13-20/h2-9,18H,10-13H2,1H3

HIDE SMILES / InChI

Molecular Formula	C18H20N2O
Molecular Weight	280.3642
Charge	0
Count

Stereochemistry	MIXED
Additional Stereochemistry	No
Defined Stereocenters	0 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

PubMed

Title	Date	PubMed
Pharmacological aspects of mianserin.	1983	6301219
Postjunctional effects of mianserin and its metabolites on the rat isolated anococcygeus muscle.	1985 Feb	2858543

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:17:34 UTC 2023` Edited by `admin` on `Sat Dec 16 09:17:34 UTC 2023`
Record UNII	WWZ32657N1
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MIANSERIN 2-OXIDE

Common Name

English

DIBENZO(C,F)PYRAZINO(1,2-A)AZEPINE, 1,2,3,4,10,14B-HEXAHYDRO-2-METHYL-, 2-OXIDE

Systematic Name

English

MS-N OXIDE

Common Name

English

MIANSERIN-N-OXIDE

Common Name

English

Code System Code Type Description

FDA UNII

WWZ32657N1

Created by admin on Sat Dec 16 09:17:34 UTC 2023 , Edited by admin on Sat Dec 16 09:17:34 UTC 2023

PRIMARY

PUBCHEM

3085244

Created by admin on Sat Dec 16 09:17:34 UTC 2023 , Edited by admin on Sat Dec 16 09:17:34 UTC 2023

PRIMARY

CAS

62510-46-7

Created by admin on Sat Dec 16 09:17:34 UTC 2023 , Edited by admin on Sat Dec 16 09:17:34 UTC 2023

PRIMARY

EPA CompTox

DTXSID70891482

Created by admin on Sat Dec 16 09:17:34 UTC 2023 , Edited by admin on Sat Dec 16 09:17:34 UTC 2023

PRIMARY

Related Record Type Details


					250PJI13LM

MIANSERIN

PARENT -> METABOLITE